TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi

Alvotech announced the European market launch of Gobivaz, the first-ever biosimilar to Simponi (golimumab), through partner Advanz Pharma. NHS England selected Gobivaz following a competitive tender, supporting the health service's strategy to increase patient access to high-quality biopharmaceuticals. The drug is manufactured in Alvotech's Reykjavik facility.

Insights
ALVO   positive

Alvotech achieved a significant milestone with the first-ever global market launch of a Simponi biosimilar, secured NHS England's competitive tender award, and is expanding European market presence with manufacturing capabilities in Iceland.